Grant Life Sciences

Notice of Allowance issued for blood test that detects HPV-associated cancers

Published in Law and Health Weekly, February 5th, 2005

Grant Life Sciences (OTC Bulletin Board: GLIF) announced that it has received a "Notice of Allowance" from the U.S. Patent and Trademark Office related to the first of the company's international patent applications.

The application is titled "Peptides from the E2, E6, and E7 proteins of human papillomaviruses 16 and 18 for detecting and/or diagnosing cervical and other cancers."

"This is a significant milestone for Grant Life Sciences," said Stan Yakatan, the company's chairman and CEO. "No doubt, this patent allowance clears the way for us to aggressively pursue additional valid and enforceable rights in this area of peptides for detecting and/or...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2005-02-05)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry